Additionally, the 36-month beta value for AKBA is 0.88. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 0
AKBA has 36-month beta value of 0.86. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 0 as “overweight,”
The stock of Akebia Therapeutics Inc. (AKBA) has seen a -10.29% decrease in the past week, with a 18.83% gain in the past month, and
In the past week, AKBA stock has gone up by 16.93%, with a monthly gain of 63.70% and a quarterly surge of 84.17%. The volatility
The stock has a 36-month beta value of 0.80. Opinions on the stock are mixed, with 6 analysts rating it as a “buy,” 0 as
The stock of Akebia Therapeutics Inc. (AKBA) has gone up by 15.65% for the week, with a 11.11% rise in the past month and a
© 2024, Fueled by Smart TechOne
